These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 28472059)
1. Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients. Kim HJ; Jo MJ; Kim BR; Kim JL; Jeong YA; Na YJ; Park SH; Lee SY; Lee DH; Lee HS; Kim BH; Lee SI; Min BW; Yoo YD; Oh SC PLoS One; 2017; 12(5):e0176834. PubMed ID: 28472059 [TBL] [Abstract][Full Text] [Related]
2. Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy. Lee SH; Choi SI; Lee JS; Kim CH; Jung WJ; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH Cancer Res Treat; 2017 Jan; 49(1):141-149. PubMed ID: 27188201 [TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection. Lee SH; Min JW; Lee JS; Kim CH; Yoo YD; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH Lung Cancer; 2015 Jan; 87(1):45-52. PubMed ID: 25468147 [TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species modulator 1 expression predicts lymph node metastasis and survival in early-stage non-small cell lung cancer. Kim T; Cha YJ; Park JH; Kim A; Choi YJ; Park HJ PLoS One; 2020; 15(12):e0239670. PubMed ID: 33259495 [TBL] [Abstract][Full Text] [Related]
5. Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer. Lee SH; Lee JS; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH Lung Cancer; 2014 Aug; 85(2):175-81. PubMed ID: 24951318 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells. Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients. Kim HJ; Jo MJ; Kim BR; Kim JL; Jeong YA; Na YJ; Park SH; Lee SY; Lee DH; Kim BH; Yoo YD; Oh SC Onco Targets Ther; 2018; 11():4233-4246. PubMed ID: 30087567 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of ROMO1 and OMA1 are Potentially Biomarkers and Predict Unfavorable Prognosis in Gastric Cancer. Amini MA; Karimi J; Khodadadi I; Tavilani H; Talebi SS; Afshar B J Gastrointest Cancer; 2020 Sep; 51(3):939-946. PubMed ID: 31729644 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis]. Yuan H; Tu SL; He XJ Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272 [TBL] [Abstract][Full Text] [Related]
10. Constitutive NF-κB activation and tumor-growth promotion by Romo1-mediated reactive oxygen species production. Chung JS; Lee S; Yoo YD Biochem Biophys Res Commun; 2014 Aug; 450(4):1656-61. PubMed ID: 25044121 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Reactive Oxygen Species Modulator 1 Predicts Unfavorable Clinical Outcome in EGFR-Mutant Lung Adenocarcinomas Treated With Targeted Therapy. Kwack WG; Sung JY; Lee SH Front Oncol; 2021; 11():770230. PubMed ID: 34956890 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer. Ghasemi H; Amini MA; Pegah A; Azizi E; Tayebinia H; Khanverdilou S; Mousavibahar SH; Alizamir A Mol Biol Rep; 2020 Sep; 47(9):6497-6505. PubMed ID: 32770525 [TBL] [Abstract][Full Text] [Related]
13. Romo1 and the NF-κB pathway are involved in oxidative stress-induced tumor cell invasion. Lee S; Park YH; Chung JS; Yoo YD Int J Oncol; 2015 May; 46(5):2021-8. PubMed ID: 25673177 [TBL] [Abstract][Full Text] [Related]
14. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis. Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986 [TBL] [Abstract][Full Text] [Related]
15. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer. Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733 [TBL] [Abstract][Full Text] [Related]
16. Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study. Kong M; Sung JY; Lee SH Onco Targets Ther; 2019; 12():8263-8273. PubMed ID: 31632076 [TBL] [Abstract][Full Text] [Related]
17. Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study. Chang B; Hwang IK; Lee SH Onco Targets Ther; 2021; 14():5097-5106. PubMed ID: 34707368 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues. Pak MG; Koh HJ; Roh MS Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229 [TBL] [Abstract][Full Text] [Related]
19. Lymphatic Invasion is an Independent Adverse Prognostic Factor in Patients with Colorectal Liver Metastasis. de Ridder JA; Knijn N; Wiering B; de Wilt JH; Nagtegaal ID Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S638-45. PubMed ID: 25986865 [TBL] [Abstract][Full Text] [Related]
20. Reactive Oxygen Species Modulator 1 is Associated with Poor Survival in Patients with Non-Small Cell Lung Cancer After Stereotactic Fractionated Radiosurgery: A Retrospective Pilot Study. Kong M; Sung JY; Lee SH Onco Targets Ther; 2020; 13():8173-8180. PubMed ID: 32904444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]